OTC · Financial Statements

Biocartis Group N.V. (BIOGF) Financial Statements

$0.66 OTC: BIOGF Market Cap $65.41M

Biocartis Group N.V. most recently reported annual revenue of $57.0M, a net loss of $65.0M. Revenue grew at an average annual rate of 15.5% over the last 3 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2019202020212022
Revenue$37.0M$43.0M$48.0M$57.0M
Operating Profit$-56.0M$-47.0M$-63.0M$-47.0M
Net Profit$-64.0M$-63.0M$-71.0M$-65.0M
EPS$-1.14$-1.11$-1.24$-1.08
Op Margin-148.5%-108.7%-129.8%-81.8%

Balance Sheet (USD)

Metric2019202020212022
Total Assets$268.0M$211.0M$142.0M$114.0M
Total Liabilities$184.0M$174.0M$176.0M$145.0M
Cash$178.0M$122.0M$52.0M$25.0M
Borrowings$167.0M$151.0M$154.0M$122.0M

Cash Flow (USD)

Metric2019202020212022
Operating Cash Flow$-54.0M$-39.0M$-66.0M$-45.0M
Investing Cash Flow$-8.0M$-7.0M$-8.0M$-7.0M
Financing Cash Flow$0$-4.0M$0$0
Net Cash Flow$115.0M$-55.0M$-70.0M$-27.0M
Free Cash Flow$-57.0M$-42.0M$-69.0M$-47.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.81
FCF Yield-171.80%
Quick Ratio1.20
Interest Coverage-2.22
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
BIOGF Overview BIOGF Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.